Lifeway Foods, Inc. (NASDAQ:LWAY) Major Shareholder Sells $226,700.00 in Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Ludmila Smolyansky sold 10,000 shares of the business's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $22.67, for a total transaction of $226,700.00. Following the sale, the insider now owns 985,549 shares of the company's stock, valued at approximately $22,342,395.83. This represents a 1.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.

Ludmila Smolyansky also recently made the following trade(s):

• On Friday, January 17th, Ludmila Smolyansky sold 12,034 shares of Lifeway Foods stock. The stock was sold at an average price of $22.55, for a total value of $271,366.70.
• On Monday, January 13th, Ludmila Smolyansky sold 30,000 shares of Lifeway Foods stock. The shares were sold at an average price of $22.24, for a total value of $667,200.00.
• On Monday, January 6th, Ludmila Smolyansky sold 45,000 shares of Lifeway Foods stock. The shares were sold at an average price of $23.49, for a total value of $1,057,050.00.
• On Friday, January 3rd, Ludmila Smolyansky sold 15,000 shares of Lifeway Foods stock. The shares were sold at an average price of $24.12, for a total transaction of $361,800.00.

Lifeway Foods Trading Up 0.3 %

NASDAQ LWAY traded up $0.06 on Friday, reaching $22.45. 53,325 shares of the stock were exchanged, compared to its average volume of 74,566. Lifeway Foods, Inc. has a one year low of $9.93 and a one year high of $28.61. The firm has a market capitalization of $332.71 million, a PE ratio of 26.10 and a beta of 1.02. The company's 50-day simple moving average is $23.79 and its two-hundred day simple moving average is $21.02.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on LWAY. Noble Financial cut shares of Lifeway Foods from an "outperform" rating to a "market perform" rating in a research note on Tuesday, September 24th. StockNews.com started coverage on Lifeway Foods in a research report on Friday. They set a "hold" rating on the stock.

Institutional Trading of Lifeway Foods

A number of hedge funds and other institutional investors have recently modified their holdings of LWAY. Point72 Asset Management L.P. purchased a new position in shares of Lifeway Foods during the 3rd quarter valued at $679,000. Los Angeles Capital Management LLC purchased a new position in shares of Lifeway Foods in the third quarter valued at about $1,237,000. American Century Companies Inc. bought a new position in shares of Lifeway Foods in the second quarter worth about $593,000. Marshall Wace LLP boosted its stake in shares of Lifeway Foods by 48.5% in the second quarter. Marshall Wace LLP now owns 100,217 shares of the company's stock worth $1,280,000 after acquiring an additional 32,742 shares during the period. Finally, BNP Paribas Financial Markets grew its position in shares of Lifeway Foods by 71.2% during the third quarter. BNP Paribas Financial Markets now owns 2,778 shares of the company's stock worth $72,000 after purchasing an additional 1,155 shares in the last quarter. 36.39% of the stock is owned by hedge funds and other institutional investors.

Lifeway Foods Company Profile

Lifeway Foods, Inc produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.